TRPV6 and Vitamin D3's Role in Prostate Cancer Cell Growth
Author Information
Author(s): Lehen'kyi V'yacheslav, Raphaël Maylis, Oulidi Agathe, Flourakis Matthieu, Khalimonchyk Sergii, Kondratskyi Artem, Gordienko Dmitri V., Mauroy Brigitte, Bonnal Jean-Lois, Skryma Roman, Prevarskaya Natalia
Primary Institution: Inserm, U-1003, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France
Hypothesis
How do the antiproliferative effects of 1,25-dihydroxyvitamin D3 relate to the upregulation of the pro-oncogenic TRPV6 channel?
Conclusion
1,25-dihydroxyvitamin D3 enhances prostate cancer cell proliferation through TRPV6 channel upregulation.
Supporting Evidence
- 1,25-dihydroxyvitamin D3 increased TRPV6 expression in low-steroid conditions.
- TRPV6 knockdown reversed the pro-proliferative effects of 1,25-dihydroxyvitamin D3.
- Calcium uptake was enhanced by TRPV6 in LNCaP cells treated with 1,25-dihydroxyvitamin D3.
Takeaway
Vitamin D3 can help prostate cancer cells grow more when a specific channel, TRPV6, is active.
Methodology
The study involved cell culture, RT-PCR, quantitative real-time PCR, western-blotting, and flow cytometry to analyze the effects of 1,25-dihydroxyvitamin D3 on prostate cancer cells.
Limitations
The study primarily focused on specific cell lines and may not fully represent all prostate cancer types.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website